Hiroshi Abe, PhD
Professor, Department of Chemistry, Graduate School
Nagoya University
Shiro Akinaga, PhD
President and CEO
NANO MRNA, Co., Ltd.
Dr. Adrian Amador, PhD
Director of Process Chemistry
Cambrex
Dr. Tsubasa Aoki, PhD
Researcher
Ajinomoto Co.
Dr. Kerry Blanchard, MD, PhD
CEO, Chairman and Founder
Perpetual Medicines
Dr. Marvin Caruthers, PhD
Distinguished Professor, Biochemistry
University of Colorado
Mr. Carter Cooperman
Research Associate II
Ionis
David Craik, PhD
Professor of Biomolecular Structure
University of Queensland
Hagen Cramer, PhD
Chief Technology Officer
QurAlis
Mr. Keith Cronce
Chief Operating Officer
Fluid Air, A Division of Spraying Systems
Dr. Frederic Dargelas, PhD
Senior Director, Head of Business Development and Alliance Management
DelSiTech Ltd.
Ratmir Derda, PhD
Founder and CSO, 48 Hour Discovery
University of Alberta
Alaric Desmarchelier, PhD
Business Development Manager - Peptides
Almac Group
Dr. Tomaz Einfalt, PhD
Principal Investigator II xRNA
Novartis Institutes for BioMedical Research
Dr. Steven Fakharzadeh, MD, PhD
Global Medical Affairs Leader Immunodermatology
Janssen
Dr. Xinxin Gao, PhD
Principal Scientific Manager, Peptide Therapeutics
Genentech
Dr. Michael Gold, MD
Chief R&D Officer
Compass Pathways
Robert Gronke, PhD
Senior Principal Scientist, Technical Development
Biogen, Inc
Tamar Grossman, PhD
VP, Global Head of RNA, Gene Therapy and Delivery
Johnson & Johnson Innovative Medicine
Robert Hagopian
Director Business Development
PolyPeptide Group
Hanhua Huang, PhD
Vice President, Biology
Avidity Biosciences
Hiroshi Iwamura, PhD
Deputy Head of API Process Development Department
Chugai Pharmaceutical Co., Ltd.
Prateek Joshi
Global Product Manger
Sartorius Stedim Biotech GmbH
Dr. Michiko Kimoto, PhD
Chief Operating Officer, R&D Director
Xenolis Pte. Ltd.
Dr. Thomas Langenickel, MD, PhD
Chief Medical Officer
Ethris GmbH
Frederic Legros, PhD
CEO
ARTHEx Biotech
John Lopez, PhD
Associate Director Science & Technology
Novartis
Zdravka Medarova, PhD
Co-Founder and Chief Scientific Officer
TransCode Therapeutics
Bruce Morimoto, PhD
Vice President, Drug Development
Alto Neuroscience
Markus Muttenthaler, PhD
Associate Professor, Neuropeptide Research
The University of Queensland and University of Vienna
Mehran Nikan, PhD
Research Fellow
Ionis Pharmaceuticals
Stefan Nilsson, Ph.D.
Lipigon Pharmaceuticals AB
Dr. Christian Adam Olsen, PhD
Professor, Drug Design and Pharmacology
University of Copenhagen
Chris Oswald
Founder, Owner, and Principal Consultant
Coswald Consulting LLC
Dinesh Parmar
Associate Director Regulatory Affairs
El Djouhar Rekaï, PhD
Head of Peptide Process Development & Manufacturing
Dr. Jonathan Rittichier, PhD
Chief Scientific Officer & Co-Founder
EnPlusOne BioSciences
Thomas Rupp
Managing Director
Axolabs Berlin GmbH
Yogesh Sanghvi, PhD
President
Rasayan Inc.
Hideaki Sato
Luxna Biotech
Tomomi Sato
Associate Director
Takeda Pharmaceutical Company Limited
Dr. Dong Shen, MD, PhD
RNAimmune, Inc.
Grzegorz Sienski, PhD
Director and Project Leader
AstraZeneca
Sirat Sikka
Senior Scientist, Applications and Innovation
Thermo Fisher Scientific
Lucas Siow
CEO and Co-Founder
ProteinQure
Hiroaki Suga, PhD
Professor of Chemistry, School of Science
University of Tokyo, Japan
Dr. Masayuki Sugimoto, PhD
Manager
Nitto Denko Corporation
Blake Unterreiner
Associate VP, Business Development & Customer Relations, NASD
Agilent Technologies
Sridhar Vaddeboina, Ph.D.
Vice President, Analytical Development
Wave Life Sciences
Dr. Mate Vadovics, PhD
Postdoctoral Fellow, Norbert Pardi Lab
University of Pennsylvania
Dr. Weimin Wang, PhD
Founder & CEO
Sanegene Bio
Pengyu Xu, PhD
President and Representative Director
SynCrest Inc.
Dr. Weiliang Xu, PhD
Associate Director of Business Development
PepLib
